Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
7.95
-0.25 (-3.05%)
At close: Nov 5, 2025, 4:00 PM EST
8.02
+0.07 (0.88%)
Pre-market: Nov 6, 2025, 7:08 AM EST
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $545.64 million as of November 6, 2025. Its market cap has decreased by -21.00% in one year.
Market Cap
545.64M
Enterprise Value
188.48M
1-Year Change
-21.00%
Ranking
Category
Stock Price
$7.95
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $545.64M, a decrease of -69.60%. That is a compound annual growth rate of -21.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 545.64M | 26.88% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
| Nov 19, 2020 | 1.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 837.42B |
| Johnson & Johnson | 450.25B |
| AbbVie | 379.49B |
| UnitedHealth Group | 296.42B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 217.53B |
| Novo Nordisk | 215.64B |